Catherine L. Nutt, PhD
Assistant Molecular Pathologist
Massachusetts General Hospital
Assistant Professor of Pathology
Harvard Medical School
The general interests of our research laboratory are the biological and clinical implications of brain tumor heterogeneity. In particular, our laboratory analyzes glial tumor samples for cellular and genetic differences within each of: distinct pathologic subgroups, distinct molecular genetic subgroups, and groups of patients who have responded to treatment in a unique or distinct fashion. The lab is also investigating the clinical consequences of the microenvironment in malignant gliomas and its interplay with specific genetic backgrounds. Ultimately, the goal of the lab is to use the knowledge gained through these investigations to develop novel biomarkers and treatment strategies for improved clinical management of patients with malignant glioma.
Principal Investigator Biography
Catherine Nutt received her Ph.D. in Pathology from the University of Western Ontario, Canada in 1997. She was awarded a three year Junior Research Fellowship Award from the National Cancer Institute of Canada to continue her training as a post-doctoral fellow in the Section of Neurobiology, Yale University School of Medicine. In 2000, Dr. Nutt joined the Massachusetts General Hospital Department of Neurosurgery and the Molecular Neuro-Oncology Laboratory as a post-doctoral fellow and was subsequently promoted to Instructor of Pathology. She is currently an Assistant Molecular Pathologist at Massachusetts General Hospital and an Assistant Professor of Pathology at Harvard Medical School.